Cubist Systematic Strategies »

Silence Therapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $842k 46k 18.18
2024-06-30 $179k 9.4k 19.00
2024-03-31 $784k 36k 21.60
2023-03-31 $16k 2.6k 6.20
2022-09-30 $5.0k 500 10.00
2021-12-31 $4.0k 184 21.74

More positions owned by Cubist Systematic Strategies

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Microsoft Corporation (MSFT)
Super Micro Computer Call Option (SMCI)
General Motors Company (GM)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
Micron Technology Call Option (MU)
Arm Holdings Sponsored Ads Call Option (ARM)
Intel Corporation Call Option (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Snowflake Cl A (SNOW)
Tesla Motors Call Option (TSLA)

View all positions for Cubist Systematic Strategies

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Logos Global Management
Deep Track Capital
Frazier Life Sciences Management
Nextech Invest
Henderson Group
Eventide Asset Management
Cormorant Asset Management
Ikarian Capital
5AM Venture Management
Point72 Asset Management
Citadel Advisors
Woodline Partners

View all funds holding Silence Therapeutics